248 related articles for article (PubMed ID: 19489596)
1. Antileishmaniasis activity of flavonoids from Consolida oliveriana.
Marín C; Boutaleb-Charki S; Díaz JG; Huertas O; Rosales MJ; Pérez-Cordon G; Guitierrez-Sánchez R; Sánchez-Moreno M
J Nat Prod; 2009 Jun; 72(6):1069-74. PubMed ID: 19489596
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic activities of flavonoid glycoside acetates from Consolida oliveriana.
Díaz JG; Carmona AJ; Torres F; Quintana J; Estévez F; Herz W
Planta Med; 2008 Feb; 74(2):171-4. PubMed ID: 18214815
[TBL] [Abstract][Full Text] [Related]
3. An in vitro micromethod for drug sensitivity testing of Leishmania.
Jackson JE; Tally JD; Tang DB
Am J Trop Med Hyg; 1989 Sep; 41(3):318-30. PubMed ID: 2552851
[TBL] [Abstract][Full Text] [Related]
4. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro evaluation of leishmanicidal and trypanocidal activities of N-quinolin-8-yl-arylsulfonamides.
da Silva LE; Joussef AC; Pacheco LK; da Silva DG; Steindel M; Rebelo RA; Schmidt B
Bioorg Med Chem; 2007 Dec; 15(24):7553-60. PubMed ID: 17889546
[TBL] [Abstract][Full Text] [Related]
6. Glucantime resistant Leishmania promastigotes are sensitive to pentostam.
Moreira ES; Guerra JB; Petrillo-Peixoto Mde L
Rev Soc Bras Med Trop; 1992; 25(4):247-50. PubMed ID: 1340539
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
Grogl M; Thomason TN; Franke ED
Am J Trop Med Hyg; 1992 Jul; 47(1):117-26. PubMed ID: 1322070
[TBL] [Abstract][Full Text] [Related]
8. Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
Gonçalves GS; Fernandes AP; Souza RC; Cardoso JE; de Oliveira-Silva F; Maciel FC; Rabello A; Ferreira LA
Acta Trop; 2005 Feb; 93(2):161-7. PubMed ID: 15652330
[TBL] [Abstract][Full Text] [Related]
9. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
Rojas R; Valderrama L; Valderrama M; Varona MX; Ouellette M; Saravia NG
J Infect Dis; 2006 May; 193(10):1375-83. PubMed ID: 16619185
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo cytotoxicities and antileishmanial activities of thymol and hemisynthetic derivatives.
Robledo S; Osorio E; Muñoz D; Jaramillo LM; Restrepo A; Arango G; Vélez I
Antimicrob Agents Chemother; 2005 Apr; 49(4):1652-5. PubMed ID: 15793164
[TBL] [Abstract][Full Text] [Related]
11. Activity of a hydroxybibenzyl bryophyte constituent against Leishmania spp. and Trypanosoma cruzi: in silico, in vitro and in vivo activity studies.
Roldos V; Nakayama H; Rolón M; Montero-Torres A; Trucco F; Torres S; Vega C; Marrero-Ponce Y; Heguaburu V; Yaluff G; Gómez-Barrio A; Sanabria L; Ferreira ME; Rojas de Arias A; Pandolfi E
Eur J Med Chem; 2008 Sep; 43(9):1797-807. PubMed ID: 18192088
[TBL] [Abstract][Full Text] [Related]
12. The antileishmanial activity assessment of unusual flavonoids from Kalanchoe pinnata.
Muzitano MF; Tinoco LW; Guette C; Kaiser CR; Rossi-Bergmann B; Costa SS
Phytochemistry; 2006 Sep; 67(18):2071-7. PubMed ID: 16930642
[TBL] [Abstract][Full Text] [Related]
13. Leishmanicidal constituents from the leaves of Piper rusbyi.
Flores N; Cabrera G; Jiménez IA; Piñero J; Giménez A; Bourdy G; Cortés-Selva F; Bazzocchi IL
Planta Med; 2007 Mar; 73(3):206-11. PubMed ID: 17354169
[TBL] [Abstract][Full Text] [Related]
14. Kahalalide F, an antitumor depsipeptide in clinical trials, and its analogues as effective antileishmanial agents.
Cruz LJ; Luque-Ortega JR; Rivas L; Albericio F
Mol Pharm; 2009; 6(3):813-24. PubMed ID: 19317431
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and leishmanicidal activities of 1-(4-X-phenyl)-N'-[(4-Y-phenyl)methylene]-1H-pyrazole-4-carbohydrazides.
Bernardino AM; Gomes AO; Charret KS; Freitas AC; Machado GM; Canto-Cavalheiro MM; Leon LL; Amaral VF
Eur J Med Chem; 2006 Jan; 41(1):80-7. PubMed ID: 16300859
[TBL] [Abstract][Full Text] [Related]
16. Flavonoids and biological activities of Jussiaea repens.
Marzouk MS; Soliman FM; Shehata IA; Rabee M; Fawzy GA
Nat Prod Res; 2007 May; 21(5):436-43. PubMed ID: 17487615
[TBL] [Abstract][Full Text] [Related]
17. Leishmanicidal, antiproteolytic and antioxidant evaluation of natural biflavonoids isolated from Garcinia brasiliensis and their semisynthetic derivatives.
Gontijo VS; Judice WA; Codonho B; Pereira IO; Assis DM; Januário JP; Caroselli EE; Juliano MA; de Carvalho Dosatti A; Marques MJ; Viegas Junior C; Henrique dos Santos M
Eur J Med Chem; 2012 Dec; 58():613-23. PubMed ID: 23178961
[TBL] [Abstract][Full Text] [Related]
18. [Search for and development of antileishmaniasis preparations (a review of the literature)].
Chistiakov DA; Drabkina AA; Rusak LV
Med Parazitol (Mosk); 1982; 51(4):57-63. PubMed ID: 6752683
[No Abstract] [Full Text] [Related]
19. A pyrimidine-beta-carboline and other alkaloids from Annona foetida with antileishmanial activity.
Costa EV; Pinheiro ML; Xavier CM; Silva JR; Amaral AC; Souza AD; Barison A; Campos FR; Ferreira AG; Machado GM; Leon LL
J Nat Prod; 2006 Feb; 69(2):292-4. PubMed ID: 16499336
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of In vitro and In vivo Drug Efficacy Over Leishmania tropica: A Pilot Study.
Özbilgin A; Çavuş İ; Yıldırım A; Kaya T; Ertabaklar H
Turkiye Parazitol Derg; 2018 Mar; 42(1):11-19. PubMed ID: 29780014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
